Ludwig Cancer Research scientists have devised new types of chimeric antigen-receptor (CAR) T cells—a type of cancer immunotherapy—that can be switched on to varying degrees of intensity and ...
Patients with a fast-spreading blood cancer respond well to outpatient treatment with CAR-T therapy, the largest study examining its use in a community setting has found. CAR-T is shorthand for ...
Department of Microbiology and Molecular Biology, Brigham Young University, Provo, UT, United States Chimeric antigen receptor (CAR) T cell therapy has become an important treatment for hematological ...
CAR-T cells are already used today to treat a number of blood cancers, but solid tumors continue to pose significant challenges for this mode of therapy in terms of both safety and efficacy.